Platforms Compete to Own Clinical Day

The market is shifting from single purpose doctor tools to workflow bundles that try to own the whole clinical day. OpenEvidence started with research search, Abridge started with ambient note capture, and Doximity started with physician communication and network distribution. Now each is adding the others core jobs, because the winning product is the one a doctor can keep open from patient visit through charting, calling, and treatment lookup.1 2 3 4 5 6

• OpenEvidence used a free research product to reach roughly 40 percent of U.S. physicians, then added Visits for note drafting and Dialer for calling. That turns a research tab into a daily workflow surface, and gives it more moments to show ads and gather usage data.1 3 4
• Abridge is moving the other direction. It began by turning patient conversations into billing ready notes inside Epic, then added NEJM and JAMA evidence directly into that workflow. That lets a doctor move from what the patient said to what the literature suggests without leaving the chart.2 5 6
• Doximity already has the physician audience and communication rails. It now bundles Ask, Scribe, drug research, scheduling, and Dialer, and in 2025 added Pathway through acquisition. In practice that means a doctor can search, document, message, and call inside one logged in product.1 7 8 9

The next phase is a land grab for default physician attention. The strongest platform will be the one that can connect evidence lookup, ambient documentation, and communication tightly enough that doctors stop switching tabs. That raises switching costs, expands monetization beyond the original wedge, and turns point solutions into broader clinical operating systems.1 2 3 7 8 9